Developer docs
API playgroundTry for free, no card

Search company profiles

UNeMed Corporation

Full company profile

uuid000ejta

Namestring
UNeMed Corporation
Legal namestring
UNeMed Corporation
Websiteurl
unemed.com
Company typeenum
Private
Founded yearint
1991
Descriptiontext

UNeMed Corporation is the officially designated technology transfer and commercialization office for the University of Nebraska Medical Center (UNMC) and the University of Nebraska at Omaha (UNO). Founded in 1991 and headquartered in Omaha, Nebraska, the organization processes approximately 100 new invention disclosures annually from university faculty, staff, and students, manages intellectual property (including a portfolio of medical devices, therapeutics, diagnostics, drug-delivery platforms, research tools, and software), executes confidentiality and material-transfer agreements, runs patent prosecution, and structures licensing deals and startup formations. Its primary "customer" on the supply side is the internal UNMC/UNO research community, served free of charge, while its commercial counterparties are licensees and equity-held spinouts such as Goldenrod Therapeutics, Carecubes, Precision Syringe, Docology, RespirAI, and NeuralRegen.

The underlying "technology" UNeMed manages spans the full UNMC and UNO research output, including novel molecules (PDE4B selective inhibitors), automated medical devices (Automated REBOA, Cardiac Vascular Access Graft, Boedeker Suction Catheter), biologics platforms (Parkinson's vaccine, nanogels, nanoformulations for HIV), research tools (GEMs for COVID-19, NR-6-R cells, Panc02-MUC1 cells), prosthetics, biosensors (DLP 3D-printed wearable hydrogels), and cuffless wearable blood-pressure monitoring. UNeMed does not develop these innovations itself; it provides the institutional machinery — invention intake, IP protection, licensing frameworks, and equity structuring — to bring them to market.

UNeMed generates revenue primarily through licensing royalties (upfront fees, milestone payments, and ongoing royalties from commercialization), equity stakes in spin-out companies, and modest fees from confidentiality and material-transfer agreements. A small online store sells branded merchandise (tech-transfer maps, t-shirts, tumblers) at unit prices ranging from $12.95 to $240. Go-to-market is sales-led and community-led: direct engagement with faculty, recurring events (Idea Pub: Morning Edition, Innovations & Libations, Startup Showcase), the 16-week Steel Works Health Accelerator co-developed with UNeTech Institute and CQuence Health, the annual Innovation Week with Innovation Awards and Demo Day, the Back-o-the-Napkin Contest, and ecosystem partnerships with NMotion/gener8tor, the Greater Omaha Chamber, the Nebraska Department of Economic Development, the U.S. Small Business Administration, and regional investors such as MOVE Venture Capital. UNeMed is co-located with UNeTech at the Catalyst building in Omaha's EDGE District and runs an exclusive "Innovation by Nebraska" co-branding program that allows licensed companies to display the UNMC shield or UNO "O" mark.

Short descriptiontext

UNeMed Corporation is the technology transfer and commercialization office for the University of Nebraska Medical Center and the University of Nebraska at Omaha, managing invention disclosures, IP, licensing, and startup formation for university innovators and licensee companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersOmaha, United States
HQ citystring
Omaha
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
technology transfer services, intellectual property licensing, university commercialization, invention disclosure management, biomedical startup formation
NAICS code1 code
  • Professional, Scientific, and Technical Services54
SIC code1 code
  • Patent Owners & Lessors6794
Product category
Technology Transfer & IP Commercialization
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Technology Licensing Royalties
TypeLicensing Royalties
Description

UNeMed generates revenue by licensing UNMC and UNO technologies to companies. Licensing deals may include upfront fees, milestone payments, and ongoing royalties from commercialization of licensed technologies.

unemed.com
2Startup Equity/Stake in Spun-out Companies
TypeLicensing Royalties
Description

UNeMed forms startup companies around university innovations and may take equity stakes in these spinouts as part of the commercialization arrangement, with the Startup Wall celebrating companies that represent over $200 million in investments.

unemed.com
3Confidentiality and Material Transfer Agreement Fees
TypeProfessional Services
Description

Fees from executing confidentiality agreements (CDA/NDA) and material transfer agreements (MTA) as part of the technology transfer process.

unemed.com
4Merchandise Sales
TypeHardware Sales
Description

UNeMed operates an online store selling branded merchandise including tech transfer maps, annual reports, t-shirts, tumblers, journals, and sport bottles. Price range for map: $30–$240; t-shirts: $18–$20; tumblers: $12.95; journals: $12.95; sport bottles: $20.00.

unemed.com
Marketing channels11 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details4 tiers
1Core tech transfer services (invention disclosure, IP management, licensing) for university innovators
ModelOtherBilling cadenceAnnual
Notes

Free to UNMC and UNO faculty, staff, and students. UNeMed covers costs of patent filing and prosecution, recouping investment through licensing revenues.

unemed.com
2Tech transfer map (printed, custom-framed)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Price range: $30.00 through $240.00 depending on finish (matte/gloss/laminated), framing options (unmounted/mounted foam core/mounted & framed), and customizations.

unemed.com
3Technology Transfer Boot Camp
ModelFreemiumBilling cadenceAnnual
Notes

Free to attend for anyone within the University of Nebraska system. Space is limited; applications reviewed in order received until filled.

unemed.com
4Annual reports (printed)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$3.00 per copy. Available for years 2013–2018.

unemed.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

UNeMed Corporation is the technology transfer and commercialization office for the University of Nebraska Medical Center (UNMC) and the University of Nebraska at Omaha (UNO). It processes approximately 100 invention disclosures per year, manages intellectual property (patents, copyrights), executes confidentiality and material transfer agreements, licenses university-developed technologies to industry, and forms startup companies around those innovations. Its portfolio spans medical devices, therapeutics, diagnostics, drug delivery platforms, research tools, and software, supported by accelerator programs (Steel Works Health Accelerator) and community events (Idea Pub, Innovation Week).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Processes approximately 100 new inventions per year from UNMC and UNO researchers
+4 more records
Product overview1 text field

UNeMed Corporation is the technology transfer and commercialization office for the University of Nebraska Medical Center and University of Nebraska at Omaha. The company offers a portfolio of services including technology licensing, startup formation, IP management, and innovation programs. Their technology portfolio includes medical devices (sympathetic vasomotion monitoring, portable laparoscope, cardiac vascular access graft, Boedeker suction catheter, automated REBOA device), therapeutics (osteotropic hydrogel, wearable hydrogels, vaccine strategy for Parkinson's disease), research tools (GEMs for COVID-19, NR-6-R cells, Panc02-MUC1 cells), software platforms, and prosthetics. UNeMed also runs accelerator programs (Steel Works Health Accelerator) and networking events (Idea Pub: Morning Edition, Innovation Week) to support university innovators and startups.

Product and service11 records
1Technology Licensing Services
CategoryTechnology Transfer Services
Description

End-to-end licensing service for UNMC and UNO innovations, including IP protection, patent prosecution, license negotiation, royalty collection, and compliance management. For university inventors and external companies seeking to commercialize university-developed technologies.

2Startup Formation Services
CategoryStartup Formation Services
Description

Service for creating new startup companies built around licensed university technologies, including entity formation, equity structuring, founder matching, investor introductions, and operational handoff to UNeTech Institute. For university researchers and external entrepreneurs.

3Invention Disclosure Processing
CategoryIP Management Services
Description

Service for university researchers to formally disclose inventions to UNeMed, triggering evaluation, IP protection decisions, and commercialization pathway selection. Processes approximately 100 disclosures per year from UNMC and UNO.

4Confidentiality and Material Transfer Agreement Services
CategoryLegal & IP Services
Description

Administrative services for executing Confidentiality Disclosure Agreements (CDA/NDA) and Material Transfer Agreements (MTA) to protect proprietary information and govern exchange of research materials between UNMC/UNO researchers and external partners.

5Steel Works Health Accelerator
CategoryAccelerator Program
Description

A 16-week accelerator program that helps early-stage medtech and healthtech startups develop investment-ready companies through structured mentorship, training, and investor preparation. Inaugural cohort of 6 companies graduated June 10, 2026. For pre-seed and seed-stage health tech and medtech startups.

6Boedeker Suction Catheter (Licensed Technology)
CategoryLicensed Medical Device Technology
Description

Airway management device for trauma patients undergoing intubation, invented by Ben Boedeker, MD, PhD. Winner of 2015 EMS World Innovation Award. Customizable tip fits any laryngoscope blade with continuous/intermittent suction or oxygen insufflation. Produced by Truer Medical and distributed via Karl Storz.

7Cardiac Vascular Access Graft (Licensed Technology)
CategoryLicensed Medical Device Technology
Description

Pediatric medical device for correcting heart defects, used in final stages of Fontan procedures. Replaces traditional tubes with permeable membranes to help cardiologists regulate pressure, featuring a radio-opaque ring for radiography.

8Automated REBOA Device (Licensed Technology)
CategoryLicensed Medical Device Technology
Description

Automated hemorrhage control system for resuscitative endovascular balloon occlusion of the aorta. Reduces deaths from catastrophic internal bleeding by maintaining blood supply to vital organs while bypassing damaged areas.

9Cuffless Blood Pressure Monitoring System (Licensed Technology)
CategoryLicensed Medical Device Technology
Description

Cuffless blood pressure monitoring system for wearable devices using pulse wave velocity measurement. Resistant to error, compatible with any device measuring ECG and PPG signals, allowing individuals to acquire high-quality measurements with minimal training.

10Parkinson's Disease Vaccine (Licensed Technology)
CategoryLicensed Therapeutic Technology
Description

Therapeutic vaccine combining nitrated alpha-synuclein (N-α-Syn) with vasoactive intestinal peptide (VIP) adjuvant. Elicits adaptive immune response preventing neuronal damage, demonstrating 91 percent survival rate of dopaminergic neurons in preclinical studies.

11MedLens Smartphone Diagnostic Attachment (Licensed Technology)
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership19 partners
Strategic tierNotableTypeStrategic or Co-development PartnerAnnounced on2026-06-25
Description

Docology is a Nebraska healthcare startup with AI-powered EMR automation technology. Presented at Idea Pub: Morning Edition; recently closed a successful seed round and kicked off a pilot program for its software package.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-06-25
Description

Arbor Bank provides complimentary refreshments at Idea Pub: Morning Edition events, serving as a co-sponsor of the networking series.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-08
Description

Goldenrod Therapeutics was established by UNeMed in 2023 to develop the 11h PDE4B inhibitor molecule created by UNMC chemist Corey Hopkins, PhD. UNeMed created the licensing framework and continues to support the company's development. Goldenrod raised a $6.5M seed round led by Ataxia Ventures and an affiliate of Fannin Partners.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-21
Description

UNeTech Institute is the University of Nebraska's startup incubator supporting entrepreneurial efforts built on university innovations. UNeMed and UNeTech share office space in the Catalyst building, deepening coordination on startup pipeline — UNeMed handles IP and company formation, UNeTech provides operational support (commercial thesis refinement, early customers, operator recruitment, investor meetings).

5Open Range & Techstars Omaha
Strategic tierNotableTypeGTM or Marketing PartnerAnnounced on2026-05-20
Description

Open Range and Techstars Omaha hosted Startup Weekend at Catalyst Omaha (June 5-7), encouraging 'startup-curious' university faculty, staff, and students to participate. UNeMed promoted the event to its innovator community.

unemed.com
Strategic tierMajorTypeGTM or Marketing PartnerAnnounced on2026-04-15
Description

NMotion (powered by gener8tor) organized the Gr8er Plains Summit in collaboration with UNeMed, Greater Omaha Chamber, Nebraska Dept. of Economic Development, and UNeTech. The summit aims to attract active startup investors to Midwest VC-backed startups, coinciding with the Berkshire Hathaway Annual Shareholders Meeting. International delegations from Israel and Canada will attend.

Strategic tierMajorTypeGTM or Marketing PartnerAnnounced on2026-04-15
Description

The Greater Omaha Chamber co-organized the Gr8er Plains Summit with UNeMed and other partners, aimed at building a deeper investor bench for Nebraska startups.

Strategic tierMajorTypeGTM or Marketing PartnerAnnounced on2026-04-15
Description

Nebraska Dept. of Economic Development co-organized the Gr8er Plains Summit to attract investment capital to the state and build follow-on capital for Nebraska startups.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-15
Description

Catalyst Omaha is a innovation hub in the EDGE District where UNeMed and UNeTech are co-located. The Forge Event Hall within Catalyst hosts UNeMed's Idea Pub: Morning Edition events, Steel Works Health Accelerator programming, and other entrepreneurial events. Co-sponsors Morning Edition and provides free facility tours.

10Precision Syringe
Strategic tierNotableTypeStrategic or Co-development PartnerAnnounced on2026-03-31
Description

Precision Syringe was founded on an innovation created by former UNMC pediatric ophthalmologist Danny Suh, MD — a precision syringe for delicate eye injections. CEO Adrian Blake presented at Idea Pub: Morning Edition; company is preparing for FDA submission and Series A financing.

unemed.com
Strategic tierNotableTypeStrategic or Co-development PartnerAnnounced on2026-03-26
Description

Carecubes is a medtech startup that developed its FDA-cleared ISTARI product in collaboration with the University of Nebraska Medical Center. UNeMed facilitated the technology transfer that enabled Carecubes' development, and the company recently closed a $6.5M Series A round led by Schooner Capital, Lifeforce Capital, and CQuence Health.

Strategic tierNotableTypeStrategic or Co-development PartnerAnnounced on2026-03-26
Description

NeuralRegen is a startup developing colostrum-based neuroprotective therapies for Alzheimer's and Parkinson's diseases, co-founded by Howard Gendelman, MD, Chair of UNMC's Department of Pharmacology and Experimental Neuroscience. UNeMed facilitated the technology transfer. The company partnered with Oehlerking Dairy Farm in Elmwood, Nebraska for colostrum supply.

13Oehlerking Dairy Farm
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-03-26
Description

Oehlerking Dairy Farm in Elmwood, Nebraska provides the colostrum (first milk) needed by NeuralRegen to develop its nutrient-dense neuroprotective therapies.

unemed.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-24
Description

The University of Nebraska System partnered with CQuence Health, UNeMed, and UNeTech Institute to launch the Steel Works Health Accelerator — a 16-week program supporting early-stage health tech startups. The pilot was funded by a $75,000 SBA grant. UNeMed provides technology transfer and startup formation expertise; UNeTech provides operational startup support.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-24
Description

CQuence Health is a local venture organization focused on healthcare-related startups. Partnered with UNeMed and UNeTech to design and co-sponsor the Steel Works Health Accelerator. CEO Kyle Salem expressed vision for Omaha to become the next U.S. biomedical hub.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-01-24
Description

UNMC Great Plains IDeA-CTR co-sponsored the Back-o-the-Napkin Contest with UNeMed, which awarded its 2026 prize to a cross-campus retinal disease monitoring platform collaboration.

17SuhHermsen.com
Strategic tierMinorTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2019-01-01
Description

The ergonomic surgical loupe head strap invented by Dr. Donny Suh (former UNMC pediatric ophthalmologist) and James Hermsen is available for purchase at SuhHermsen.com, managed by UNeMed for licensing discussions.

unemed.com
Strategic tierNotableTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2015-01-01
Description

Truer Medical produces the Boedeker Suction Catheter, invented by Dr. Ben Boedeker at UNMC and managed by UNeMed. The device won a 2015 EMS World Innovation Award.

Strategic tierNotableTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2015-01-01
Description

Karl Storz distributes a version of the Boedeker Suction Catheter. The catheter is a single-use, disposable device with customizable tip for attaching to any laryngoscope blade, featuring continuous/intermittent suction or oxygen insufflation.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of the oldest university technology transfer organizations in the U.S., managing patents and licensing for University of Wisconsin–Madison discoveries. Comparable in its biotech/medtech focus and equity stake strategy in spinouts.

TypeDirect peer
Description

Stanford's OTL handles all invention disclosures, patent prosecution, and licensing for Stanford University innovations. Direct functional peer for university IP commercialization.

TypeDirect peer
Description

Technology transfer office for Johns Hopkins University, one of the largest academic medical centers in the U.S. Directly comparable in mandate: licensing IP, forming startups, and running commercialization programs from biomedical research output.

TypeDirect peer
Description

MIT's centralized tech transfer office handling invention disclosures, patenting, licensing, and startup formation. Directly comparable mission and structure to UNeMed's operations at UNMC/UNO.

TypeRegional player
Description

University of Minnesota's tech transfer office in the upper Midwest. Comparable in geographic proximity and biomedical research mix, with a broader portfolio and more resources than UNeMed.

TypeDirect peer
Description

Tech transfer office at Case Western Reserve University handling IP protection, licensing, and startup creation. Comparable biomedical-heavy portfolio with similar operating scale.

TypeRegional player
Description

Regional Midwestern university tech transfer organization, comparable in geography and similar mid-sized biomedical research base. Lighter operating footprint and similar ecosystem positioning to UNeMed.

TypeDirect peer
Description

Tech transfer office for Washington University in St. Louis, a leading biomedical research institution. Operates a directly analogous model of licensing and startup formation around academic medical research output.

TypeDirect peer
Description

Emory's TTO commercializes inventions from Emory's medical and health sciences research. Direct functional peer in licensing biomedical IP and supporting university spinouts.

TypeDirect peer
Description

University of Michigan's tech transfer and commercialization arm. Comparable operating model: licensing inventions, forming startups, and accelerating health-tech ventures from a large research portfolio.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

UNeMed Corporation

Technology Transfer & IP Commercializationunemed.com

UNeMed Corporation is the technology transfer and commercialization office for the University of Nebraska Medical Center and the University of Nebraska at Omaha, managing invention disclosures, IP, licensing, and startup formation for university innovators and licensee companies.

What UNeMed Corporation does

UNeMed Corporation is the officially designated technology transfer and commercialization office for the University of Nebraska Medical Center (UNMC) and the University of Nebraska at Omaha (UNO). Founded in 1991 and headquartered in Omaha, Nebraska, the organization processes approximately 100 new invention disclosures annually from university faculty, staff, and students, manages intellectual property (including a portfolio of medical devices, therapeutics, diagnostics, drug-delivery platforms, research tools, and software), executes confidentiality and material-transfer agreements, runs patent prosecution, and structures licensing deals and startup formations. Its primary "customer" on the supply side is the internal UNMC/UNO research community, served free of charge, while its commercial counterparties are licensees and equity-held spinouts such as Goldenrod Therapeutics, Carecubes, Precision Syringe, Docology, RespirAI, and NeuralRegen.

The underlying "technology" UNeMed manages spans the full UNMC and UNO research output, including novel molecules (PDE4B selective inhibitors), automated medical devices (Automated REBOA, Cardiac Vascular Access Graft, Boedeker Suction Catheter), biologics platforms (Parkinson's vaccine, nanogels, nanoformulations for HIV), research tools (GEMs for COVID-19, NR-6-R cells, Panc02-MUC1 cells), prosthetics, biosensors (DLP 3D-printed wearable hydrogels), and cuffless wearable blood-pressure monitoring. UNeMed does not develop these innovations itself; it provides the institutional machinery — invention intake, IP protection, licensing frameworks, and equity structuring — to bring them to market.

UNeMed generates revenue primarily through licensing royalties (upfront fees, milestone payments, and ongoing royalties from commercialization), equity stakes in spin-out companies, and modest fees from confidentiality and material-transfer agreements. A small online store sells branded merchandise (tech-transfer maps, t-shirts, tumblers) at unit prices ranging from $12.95 to $240. Go-to-market is sales-led and community-led: direct engagement with faculty, recurring events (Idea Pub: Morning Edition, Innovations & Libations, Startup Showcase), the 16-week Steel Works Health Accelerator co-developed with UNeTech Institute and CQuence Health, the annual Innovation Week with Innovation Awards and Demo Day, the Back-o-the-Napkin Contest, and ecosystem partnerships with NMotion/gener8tor, the Greater Omaha Chamber, the Nebraska Department of Economic Development, the U.S. Small Business Administration, and regional investors such as MOVE Venture Capital. UNeMed is co-located with UNeTech at the Catalyst building in Omaha's EDGE District and runs an exclusive "Innovation by Nebraska" co-branding program that allows licensed companies to display the UNMC shield or UNO "O" mark.

UNeMed Corporation firmographics

Firmographics
Name
UNeMed Corporation
Legal name
UNeMed Corporation
Website
https://unemed.com
Company type
Private
Founded year
1991
Operating status
Operating
Headcount range
11–50 employees
Short description
UNeMed Corporation is the technology transfer and commercialization office for the University of Nebraska Medical Center and the University of Nebraska at Omaha, managing invention disclosures, IP, licensing, and startup formation for university innovators and licensee companies.
Ownership category
akta.pro rank

Where UNeMed Corporation is headquartered

Location

Headquarters

HQ city
Omaha
HQ country
United States
HQ region
North America

Offices1 record

Markets served

UNeMed Corporation business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Technology Licensing Royalties: UNeMed generates revenue by licensing UNMC and UNO technologies to companies. Licensing deals may include upfront fees, milestone payments, and ongoing royalties from commercialization of licensed technologies.
  2. Startup Equity/Stake in Spun-out Companies: UNeMed forms startup companies around university innovations and may take equity stakes in these spinouts as part of the commercialization arrangement, with the Startup Wall celebrating companies that represent over $200 million in investments.
  3. Confidentiality and Material Transfer Agreement Fees: Fees from executing confidentiality agreements (CDA/NDA) and material transfer agreements (MTA) as part of the technology transfer process.
  4. Merchandise Sales: UNeMed operates an online store selling branded merchandise including tech transfer maps, annual reports, t-shirts, tumblers, journals, and sport bottles. Price range for map: $30–$240; t-shirts: $18–$20; tumblers: $12.95; journals: $12.95; sport bottles: $20.00.

Pricing tiers

ModelBillingPrice
OtherAnnualCore tech transfer services (invention disclosure, IP management, licensing) for university innovators
Unit PricingPay-as-you-goTech transfer map (printed, custom-framed)
FreemiumAnnualTechnology Transfer Boot Camp
Unit PricingPay-as-you-goAnnual reports (printed)

Go-to-market motion3 records

Distribution channels6 records

Marketing channels11 records

UNeMed Corporation product offering

Product offering

Core offering

UNeMed Corporation is the technology transfer and commercialization office for the University of Nebraska Medical Center (UNMC) and the University of Nebraska at Omaha (UNO). It processes approximately 100 invention disclosures per year, manages intellectual property (patents, copyrights), executes confidentiality and material transfer agreements, licenses university-developed technologies to industry, and forms startup companies around those innovations. Its portfolio spans medical devices, therapeutics, diagnostics, drug delivery platforms, research tools, and software, supported by accelerator programs (Steel Works Health Accelerator) and community events (Idea Pub, Innovation Week).

Product overview

UNeMed Corporation is the technology transfer and commercialization office for the University of Nebraska Medical Center and University of Nebraska at Omaha. The company offers a portfolio of services including technology licensing, startup formation, IP management, and innovation programs. Their technology portfolio includes medical devices (sympathetic vasomotion monitoring, portable laparoscope, cardiac vascular access graft, Boedeker suction catheter, automated REBOA device), therapeutics (osteotropic hydrogel, wearable hydrogels, vaccine strategy for Parkinson's disease), research tools (GEMs for COVID-19, NR-6-R cells, Panc02-MUC1 cells), software platforms, and prosthetics. UNeMed also runs accelerator programs (Steel Works Health Accelerator) and networking events (Idea Pub: Morning Edition, Innovation Week) to support university innovators and startups.

Differentiator

Problem solved

Functional benefit

Products and services

  • Technology Licensing Services End-to-end licensing service for UNMC and UNO innovations, including IP protection, patent prosecution, license negotiation, royalty collection, and compliance management. For university inventors and external companies seeking to commercialize university-developed technologies.
  • Startup Formation Services Service for creating new startup companies built around licensed university technologies, including entity formation, equity structuring, founder matching, investor introductions, and operational handoff to UNeTech Institute. For university researchers and external entrepreneurs.
  • Invention Disclosure Processing Service for university researchers to formally disclose inventions to UNeMed, triggering evaluation, IP protection decisions, and commercialization pathway selection. Processes approximately 100 disclosures per year from UNMC and UNO.
  • Confidentiality and Material Transfer Agreement Services Administrative services for executing Confidentiality Disclosure Agreements (CDA/NDA) and Material Transfer Agreements (MTA) to protect proprietary information and govern exchange of research materials between UNMC/UNO researchers and external partners.
  • Steel Works Health Accelerator A 16-week accelerator program that helps early-stage medtech and healthtech startups develop investment-ready companies through structured mentorship, training, and investor preparation. Inaugural cohort of 6 companies graduated June 10, 2026. For pre-seed and seed-stage health tech and medtech startups.
  • Boedeker Suction Catheter (Licensed Technology) Airway management device for trauma patients undergoing intubation, invented by Ben Boedeker, MD, PhD. Winner of 2015 EMS World Innovation Award. Customizable tip fits any laryngoscope blade with continuous/intermittent suction or oxygen insufflation. Produced by Truer Medical and distributed via Karl Storz.
  • Cardiac Vascular Access Graft (Licensed Technology) Pediatric medical device for correcting heart defects, used in final stages of Fontan procedures. Replaces traditional tubes with permeable membranes to help cardiologists regulate pressure, featuring a radio-opaque ring for radiography.
  • Automated REBOA Device (Licensed Technology) Automated hemorrhage control system for resuscitative endovascular balloon occlusion of the aorta. Reduces deaths from catastrophic internal bleeding by maintaining blood supply to vital organs while bypassing damaged areas.
  • Cuffless Blood Pressure Monitoring System (Licensed Technology) Cuffless blood pressure monitoring system for wearable devices using pulse wave velocity measurement. Resistant to error, compatible with any device measuring ECG and PPG signals, allowing individuals to acquire high-quality measurements with minimal training.
  • Parkinson's Disease Vaccine (Licensed Technology) Therapeutic vaccine combining nitrated alpha-synuclein (N-α-Syn) with vasoactive intestinal peptide (VIP) adjuvant. Elicits adaptive immune response preventing neuronal damage, demonstrating 91 percent survival rate of dopaminergic neurons in preclinical studies.
  • MedLens Smartphone Diagnostic Attachment (Licensed Technology)

Quantifiable outcome

  • Processes approximately 100 new inventions per year from UNMC and UNO researchers
  • +4 more outcomes

Companies that use UNeMed Corporation

Customer profile

Named customers10 records

Segments3 records

Ideal customer profiles2 records

UNeMed Corporation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

UNeMed Corporation partnerships and signals

Strategic signal

Partnerships

19 partnerships are on record, tiered notable, minor, core and major.

  • DocologynotableStrategic or Co-development Partner · 25 June 2026Docology is a Nebraska healthcare startup with AI-powered EMR automation technology. Presented at Idea Pub: Morning Edition; recently closed a successful seed round and kicked off a pilot program for its software package.
  • Arbor BankminorGTM or Marketing Partner · 25 June 2026Arbor Bank provides complimentary refreshments at Idea Pub: Morning Edition events, serving as a co-sponsor of the networking series.
  • Goldenrod TherapeuticscoreStrategic or Co-development Partner · 8 June 2026Goldenrod Therapeutics was established by UNeMed in 2023 to develop the 11h PDE4B inhibitor molecule created by UNMC chemist Corey Hopkins, PhD. UNeMed created the licensing framework and continues to support the company's development. Goldenrod raised a $6.5M seed round led by Ataxia Ventures and an affiliate of Fannin Partners.
  • UNeTech InstitutecoreStrategic or Co-development Partner · 21 May 2026UNeTech Institute is the University of Nebraska's startup incubator supporting entrepreneurial efforts built on university innovations. UNeMed and UNeTech share office space in the Catalyst building, deepening coordination on startup pipeline — UNeMed handles IP and company formation, UNeTech provides operational support (commercial thesis refinement, early customers, operator recruitment, investor meetings).
  • Open Range & Techstars OmahanotableGTM or Marketing Partner · 20 May 2026Open Range and Techstars Omaha hosted Startup Weekend at Catalyst Omaha (June 5-7), encouraging 'startup-curious' university faculty, staff, and students to participate. UNeMed promoted the event to its innovator community.
  • NMotion powered by gener8tormajorGTM or Marketing Partner · 15 April 2026NMotion (powered by gener8tor) organized the Gr8er Plains Summit in collaboration with UNeMed, Greater Omaha Chamber, Nebraska Dept. of Economic Development, and UNeTech. The summit aims to attract active startup investors to Midwest VC-backed startups, coinciding with the Berkshire Hathaway Annual Shareholders Meeting. International delegations from Israel and Canada will attend.
  • Greater Omaha ChambermajorGTM or Marketing Partner · 15 April 2026The Greater Omaha Chamber co-organized the Gr8er Plains Summit with UNeMed and other partners, aimed at building a deeper investor bench for Nebraska startups.
  • Nebraska Department of Economic DevelopmentmajorGTM or Marketing Partner · 15 April 2026Nebraska Dept. of Economic Development co-organized the Gr8er Plains Summit to attract investment capital to the state and build follow-on capital for Nebraska startups.
  • Catalyst Omaha (EDGE District)coreStrategic or Co-development Partner · 15 April 2026Catalyst Omaha is a innovation hub in the EDGE District where UNeMed and UNeTech are co-located. The Forge Event Hall within Catalyst hosts UNeMed's Idea Pub: Morning Edition events, Steel Works Health Accelerator programming, and other entrepreneurial events. Co-sponsors Morning Edition and provides free facility tours.
  • Precision SyringenotableStrategic or Co-development Partner · 31 March 2026Precision Syringe was founded on an innovation created by former UNMC pediatric ophthalmologist Danny Suh, MD — a precision syringe for delicate eye injections. CEO Adrian Blake presented at Idea Pub: Morning Edition; company is preparing for FDA submission and Series A financing.
  • Carecubes (UNMC spinoff)notableStrategic or Co-development Partner · 26 March 2026Carecubes is a medtech startup that developed its FDA-cleared ISTARI product in collaboration with the University of Nebraska Medical Center. UNeMed facilitated the technology transfer that enabled Carecubes' development, and the company recently closed a $6.5M Series A round led by Schooner Capital, Lifeforce Capital, and CQuence Health.
  • NeuralRegennotableStrategic or Co-development Partner · 26 March 2026NeuralRegen is a startup developing colostrum-based neuroprotective therapies for Alzheimer's and Parkinson's diseases, co-founded by Howard Gendelman, MD, Chair of UNMC's Department of Pharmacology and Experimental Neuroscience. UNeMed facilitated the technology transfer. The company partnered with Oehlerking Dairy Farm in Elmwood, Nebraska for colostrum supply.
  • Oehlerking Dairy FarmminorStrategic or Co-development Partner · 26 March 2026Oehlerking Dairy Farm in Elmwood, Nebraska provides the colostrum (first milk) needed by NeuralRegen to develop its nutrient-dense neuroprotective therapies.
  • University of Nebraska SystemcoreStrategic or Co-development Partner · 24 January 2026The University of Nebraska System partnered with CQuence Health, UNeMed, and UNeTech Institute to launch the Steel Works Health Accelerator — a 16-week program supporting early-stage health tech startups. The pilot was funded by a $75,000 SBA grant. UNeMed provides technology transfer and startup formation expertise; UNeTech provides operational startup support.
  • CQuence HealthcoreStrategic or Co-development Partner · 24 January 2026CQuence Health is a local venture organization focused on healthcare-related startups. Partnered with UNeMed and UNeTech to design and co-sponsor the Steel Works Health Accelerator. CEO Kyle Salem expressed vision for Omaha to become the next U.S. biomedical hub.
  • UNMC Great Plains IDeA-CTRminorStrategic or Co-development Partner · 24 January 2026UNMC Great Plains IDeA-CTR co-sponsored the Back-o-the-Napkin Contest with UNeMed, which awarded its 2026 prize to a cross-campus retinal disease monitoring platform collaboration.
  • SuhHermsen.comminorOEM/ Whitelabel/ Licensing Partner · 1 January 2019The ergonomic surgical loupe head strap invented by Dr. Donny Suh (former UNMC pediatric ophthalmologist) and James Hermsen is available for purchase at SuhHermsen.com, managed by UNeMed for licensing discussions.
  • Truer MedicalnotableOEM/ Whitelabel/ Licensing Partner · 1 January 2015Truer Medical produces the Boedeker Suction Catheter, invented by Dr. Ben Boedeker at UNMC and managed by UNeMed. The device won a 2015 EMS World Innovation Award.
  • Karl StorznotableOEM/ Whitelabel/ Licensing Partner · 1 January 2015Karl Storz distributes a version of the Boedeker Suction Catheter. The catheter is a single-use, disposable device with customizable tip for attaching to any laryngoscope blade, featuring continuous/intermittent suction or oxygen insufflation.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

UNeMed Corporation competitors and assessment

Company assessment

Direct peers

  • Wisconsin Alumni Research Foundation (WARF): One of the oldest university technology transfer organizations in the U.S., managing patents and licensing for University of Wisconsin–Madison discoveries. Comparable in its biotech/medtech focus and equity stake strategy in spinouts.
  • Stanford Office of Technology Licensing (OTL): Stanford's OTL handles all invention disclosures, patent prosecution, and licensing for Stanford University innovations. Direct functional peer for university IP commercialization.
  • Johns Hopkins Technology Ventures: Technology transfer office for Johns Hopkins University, one of the largest academic medical centers in the U.S. Directly comparable in mandate: licensing IP, forming startups, and running commercialization programs from biomedical research output.
  • MIT Technology Licensing Office: MIT's centralized tech transfer office handling invention disclosures, patenting, licensing, and startup formation. Directly comparable mission and structure to UNeMed's operations at UNMC/UNO.
  • Case Western Reserve University Technology Transfer Office: Tech transfer office at Case Western Reserve University handling IP protection, licensing, and startup creation. Comparable biomedical-heavy portfolio with similar operating scale.
  • Washington University in St. Louis - Office of Technology Management: Tech transfer office for Washington University in St. Louis, a leading biomedical research institution. Operates a directly analogous model of licensing and startup formation around academic medical research output.
  • Emory University Office of Technology Transfer: Emory's TTO commercializes inventions from Emory's medical and health sciences research. Direct functional peer in licensing biomedical IP and supporting university spinouts.
  • University of Michigan Innovation Partnerships: University of Michigan's tech transfer and commercialization arm. Comparable operating model: licensing inventions, forming startups, and accelerating health-tech ventures from a large research portfolio.

Regional players

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

UNeMed Corporation social profiles

Digital presence

UNeMed Corporation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

UNeMed Corporation leadership team

Management profile

Number of profiles

Profiles6 records

UNeMed Corporation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

UNeMed Corporation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UNeMed Corporation

What does UNeMed Corporation do?

UNeMed Corporation is the technology transfer and commercialization office for the University of Nebraska Medical Center (UNMC) and the University of Nebraska at Omaha (UNO). It processes approximately 100 invention disclosures per year, manages intellectual property (patents, copyrights), executes confidentiality and material transfer agreements, licenses university-developed technologies to industry, and forms startup companies around those innovations. Its portfolio spans medical devices, therapeutics, diagnostics, drug delivery platforms, research tools, and software, supported by accelerator programs (Steel Works Health Accelerator) and community events (Idea Pub, Innovation Week).

Is UNeMed Corporation a public or private company?

UNeMed Corporation is a private company. It is classified as state government owned and is currently operating.

When was UNeMed Corporation founded?

UNeMed Corporation was founded in 1991. It employs 11 to 50 people.

Where is UNeMed Corporation based?

UNeMed Corporation is headquartered in Omaha, United States, in the North America region.

How does UNeMed Corporation make money?

Four revenue lines are on record. Technology Licensing Royalties are the primary driver. The others are startup Equity/Stake in Spun-out Companies, confidentiality and Material Transfer Agreement Fees and merchandise Sales.

Who are UNeMed Corporation's main competitors?

Direct peers on record are Wisconsin Alumni Research Foundation (WARF), Stanford Office of Technology Licensing (OTL), Johns Hopkins Technology Ventures, MIT Technology Licensing Office, Case Western Reserve University Technology Transfer Office, Washington University in St. Louis - Office of Technology Management, Emory University Office of Technology Transfer and University of Michigan Innovation Partnerships. Regional players are University of Minnesota Technology Commercialization and University of Iowa Research Foundation (UIRF).

Does UNeMed Corporation have an API?

No public API is recorded for UNeMed Corporation.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SiliconprairienewsGoldenrod Therapeutics raises $6.5 million to test UNMC-created drug that could change modern medicineGoldenrod Therapeutics raised $6.5 million in seed funding to test 11h, a PDE4 inhibitor developed at the University of Nebraska Medical Center. The drug, which showed no nausea in ferret trials, will enter phase 1 clinical trials for Friedreich's ataxia, with FDA approval pending.SiliconprairienewsApplications open for the second cohort of the Steel Works Health AcceleratorApplications are open for the second cohort of the Steel Works Health Accelerator, a four-month program for Nebraska pre-seed healthtech startups. The deadline is July 3, and participants will receive training on pitch decks and SBIR/STTR funding applications. The program aims to prepare companies for investor presentations and seed funding.UnmcA hub for big thinkers: The Catalyst buildingThe article reports that UNeMed has processed 536 new inventions from UNMC and UNO in the past five years, resulting in 81 license agreements and 15 startup companies.SiliconprairienewsOctober award celebrations recognize scientific advancements, university research and entrepreneurial spirit in NebraskaUNeMed, the tech transfer office of the University of Nebraska System, hosted its 2025 Innovation Research Awards ceremony in Omaha, recognizing faculty inventors, startups, and ecosystem partners for contributions to bioscience and medical innovation. The event, part of the 19th annual Innovation Week, highlighted achievements including 127 new inventions and 33 U.S. patents issued in the last fiscal year, while launching an Innovation Ambassadors program to bridge faculty with the commercialization process. Award winners included Ashok Puri (Emerging Inventor), Thanh Nguyen (Faculty Entrepreneur, with 91 lifetime invention submissions), RespirAI (Startup of the Year), ADS Biotech (Governor's Bioscience Award), and Invest Nebraska (Innovation Champion), with the latter having invested $4.6 million in 12 university-affiliated startups.SiliconprairienewsInnovation Week to celebrate UNMC and UNO innovation, highlight what could be lost amid funding cuts and uncertaintyUNeMed, the tech transfer organization for the University of Nebraska Medical Center (UNMC) and University of Nebraska at Omaha (UNO), is hosting Innovation Week from Oct. 20-25 to celebrate academic research with events including a startup showcase and annual Research Innovation Awards. The event carries heightened significance amid federal and state funding cuts that have caused contraction in the University of Nebraska System and raised concerns about researchers leaving for opportunities elsewhere. Organizers hope the public showcase will build support for Nebraska's academic talent and secure the funding researchers need to continue their work in the state.UnemedStartupsUNeMed, the technology transfer organization for the University of Nebraska, supports faculty and students in commercializing university-licensed technologies by helping them form new corporate entities. The article highlights a portfolio of active startups, such as Virtual Incision Corporation and Exavir, which are developing medical devices and pharmaceuticals derived from these innovations.GlobeNewswireInnovate Conference Spotlights Nebraska’s Bioscience EcosystemOver 100 attendees gathered at UNMC for the Innovate Conference, hosted by Greater Omaha Chamber, Bio Nebraska, and UNeMed, to highlight Nebraska's bioscience and medtech leadership. The event featured a keynote, panel discussions, and VIP tours, with Governor Ricketts presenting the Bioscience Award and proclaiming October as Bioscience Month.